Analysts and investors are awaiting details behind UnitedHealth Group's 2025 outlook when it reports quarterly results on Thursday, after its investor day presentations were canceled last month by the murder of executive Brian Thompson outside the New York hotel where the meeting was set to take place.

UnitedHealth Group’s upcoming earnings call marks the company's first public appearance since the murder of UnitedHealthcare CEO Brian Thompson.

UnitedHealth's valuation metrics indicate a potential buy-the-dip opportunity, with forward ratios mostly below their five-year averages. Learn more on UNH stock here.

UnitedHealth Group Inc. is set to report financial results Thursday, the first time its executives will speak publicly since the insurance unit’s chief Brian Thompson was killed last month.

UnitedHealth Group is expected to post a sizable profit on Thursday morning when it reports its fourth-quarter and year-end earnings report, despite being hit by a historically costly cyberattack and weathering ever-rising medical costs.

Key Takeaways UnitedHealth Group is set to report fourth-quarter earnings before the market opens Thursday.All 17 analysts tracked by Visible Alpha have a “buy” or equivalent rating and the consensus price target suggests a close to 10% rise in the shares is expected.

UnitedHealth (NYSE:UNH) is scheduled to announce Q4 earnings results on Thursday, January 16th, before market open. Analysts expect a profit of $6.74 per share (+9.4% Y/Y) on revenue of $101.73B (+7.8% Y/Y).